Abstract

The evidence on how touch-based therapy acts on the brain activity opens novel cues for the treatment of chronic pain conditions for which no definitive treatment exists. Touch-based therapies, particularly those involving C-tactile (CT)-optimal touch, have gained increasing attention for their potential in modulating pain perception and improving psychological well-being. While previous studies have focused on the biomechanical effects of manual therapy, recent research has shifted towards understanding the neurophysiological mechanisms underlying these interventions. CT-optimal touch, characterized by gentle stroking that activates CT afferents, may be used to reduce pain perception in chronic pain conditions and to enhance psychological well-being. Further research is needed to fully elucidate the neurophysiological mechanisms involved and to establish the therapeutic efficacy of CT-optimal touch in various clinical populations.

1. Introduction

Touch is one of our five senses that most influences our connection with other individuals. It is used to interact with the whole environment, as well as to communicate positive messages, like reassurance, comfort, sympathy, and support with other individuals. Touch can give both pleasantness, reducing pain, and unpleasantness [1]. The personal perception of the touch is influenced by physical characteristics, like softness, temperature, force and velocity. Touch-based therapy is one of the oldest medical interventions, and it is defined as passive movements or forces applied to joints and soft tissues, typically performed by hand [2, 3]. The first organ we keep in contact with during a touch-based therapy is clearly the skin. The skin, our largest organ, plays a vital role in how we interact with the world around us. Three types of sensory fibres innervate the skin: A-Beta (Aβ), A-Delta (Aδ), and C-fibers, all of which contribute to our somatosensory experiences [4]. Traditionally, it was believed that tactile sensation was solely transmitted through fast-conducting (50 m/s) myelinated Aβ-fibers, which are known for their high spatial and temporal resolution and are associated with the discriminative aspects of touch [5]. It has been shown that a specific subset of C-fibres known as C-tactile (CT) fibres are associated with the emotional and pleasant aspects of touch, which belong to affective touch [6]. These unmyelinated, slow-conducting afferents exhibit low spatial and temporal resolution [7], and are most responsive to gentle, slow stroking of hairy skin at speeds ranging from 1 to 10 cm/s, with 3 cm/s being the optimal. This type of stimulus, whether applied with a soft brush or by hand, tends to produce pleasant sensory experiences [8]. The affective touch [9] processing system is active throughout adulthood, and it is present in very young infants. Research [10] shows that from nine months of age, infants exhibit distinct physiological responses, such as a decrease in heart rate, to slow stroking on the forearm, which is known to activate CT-fibers. Interestingly, parents naturally touch their infants in ways that optimally stimulate these fibers during social interactions [9]. Jönsson et al. [9], hypothesized that there is a cortical system able to detect affective touch early in postnatal life. Indeed, they discovered that from only two months after birth, the infant brain has a specialized system that allows it to differentiate between affective and non-affective tactile cues. In particular, when interpersonal touch is delivered as affective touch—a gentle, emotionally driven form of touch—it can be a highly effective way to evoke and influence human emotions. In contrast, people deprived of touch have increased sympathetic reactivity to emotional stimuli and poor emotional regulation [11].

This aspect is particularly critical in children. Those raised in institutional settings, where there is a lack of care and associated physical touch, are at a higher risk of behavioural, emotional, and social problems [12, 13, 14]. For instance, Wilbarger et al. [15] examined sensory processing capacities in internationally adopted children, particularly those who had experienced prolonged institutional care. Their studies underscore that post-institutionalized children often suffer long-term sensory processing disruptions due to early deprivation, which impacts their overall functioning and development [13, 15]. In this context, the role of touch in mammalian development is fundamental, as it allows management of anxiety, stress, depression, pain, and physical illness [16].

In healthcare, touch is an integral part of routine services, particularly in physiotherapy and osteopathy, where touch-based techniques are frequently employed. As a result, an increasing number of studies are examining the neurophysiological effects of touch. These studies have explored how the brain processes both discriminative touch (which involves distinguishing different stimuli) and affective touch (such as pleasant, gentle stroking) [5, 17, 18, 19]. The neurophysiological response to touch triggers the release of specific chemicals and neurotransmitters, leading to neuroendocrine changes, vagal stimulation, reduced stress, pain, and depression, and enhanced immune function [20, 21, 22]. These physiological effects support the clinical benefits of touch-based approaches, such as manual therapy [23, 24] for a wide range of musculoskeletal conditions, including low back pain as well as specific disorders like fibromyalgia [25, 26, 27]. In these disorders, where chronic pain is the predominant symptom, maladaptive neuroplastic mechanisms can easily occur at brain level, leading to changes in brain connectivity [28]. Previous studies have shown a reduction in grey matter volume in both the whole brain and specific regions, such as the cingulate cortex, prefrontal cortex, thalamus, insula, precentral cortex, temporal cortex, and praecuneus, in various chronic pain conditions [29, 30, 31]. During the process of chronification, various modulatory mechanisms have been proposed, including central sensitisation. According to some authors [32, 33], central sensitization is referred to pain hypersensitivity that can be elicited by amplified neural signalling within the central nervous system. The presence of central sensitization in patients with chronic pain can worsen the global outcomes of the patients [34].

To objectively study the role of touch at brain level, several non-invasive methods can be used. For instance, functional magnetic resonance imaging (fMRI) and the blood oxygenation level dependent (BOLD) technique allow the detection of active brain areas by searching for changes in deoxyhaemoglobin, which reflects the underlying neuronal activity and neurovascular coupling, thus providing insights into neural functioning [35]. In addition, electroencephalography (EEG) allows the registration of neurophysiological brain activity, investigating the temporal domain and therefore the real-time neuronal processes that determine the sensation of touch. These neuroimaging devices could be useful to individuate objectively neurophysiological changes due to touch-based interventions in both healthy individuals, but also in people affected by chronic pain.

By reporting the effects of touch on brain structures and functions, this opinion aims to discuss the potential mechanisms through which touch-based therapies, especially CT-optimal touch, can modulate pain perception, alleviate chronic pain, and potentially improve therapeutic outcomes in patients suffering from chronic musculoskeletal and other conditions causing chronic pain.

2. Clinical Benefits and Neurophysiological Impact of Touch-based Interventions in Patients with Chronic Pain

Among touch-based interventions, CT-optimal touch is a gentle stroking of the skin, which activates the small unmyelinated CT afferent nerves. This type of touch, also known as gentle touch, can produce pleasant sensations [36, 37]. The significance of CT-optimal touch lies in its ability to influence pain processing pathways, offering a potential approach for pain relief in various clinical settings. Recent behavioral studies have shown that CT-optimal touch can reduce pain perception in humans [38, 39, 40]. This can be explained by a model suggesting that the CT-afferent system interacts with the medial pain system at various levels of the central nervous system [41]. In fact, it may inhibit pain signals at the dorsal horn of the spinal cord, thereby preventing higher-order processing of these signals [42]. Additionally, it can downregulate several cortical areas, such as the insula and anterior cingulate cortex (ACC), which play key roles in the affective aspects of pain perception [39, 43, 44]. This mechanism places CT-optimal touch as a valuable tool for targeting both the sensory and emotional dimensions of pain. Moreover, CT-fibers respond to both static (e.g., hugging and holding) and dynamic touch, these features being relevant for understanding the perception of social touches, like hugging and handholding. According to Ali et al. [45], static touch was preferred over dynamic CT non-optimal touch (i.e., stroking touch at a velocity of <1 cm/s or >10 cm/s). At speeds outside this range, the activation frequency decreases, resulting in lower pleasantness ratings. CTs are activated by both static and dynamic touch, suggesting that variations in CT activation frequency due to different touch velocities might explain these preferences. However, when static touch, as non-CT-optimal touch, is compared with specific manual techniques, it leads to a reduced efficacy in clinical outcomes. This highlights the importance of targeting the optimal velocity and pressure in therapeutic interventions involving touch. For instance, Avichal Ughreja et al. [46]. investigated the effectiveness of specific manual techniques (e.g., cranial-sacral therapy and Bowen therapy, see [46]), which are generally CT-optimal touch-based, and a standard exercise program compared with static touch on patients with fibromyalgia. The authors found that both cranial-sacral therapy and Bowen therapy improved sleep quality, while Bowen therapy and standard exercises improved pain perception in the short-term. Furthermore, recent studies have explored whether treatments involving repeated pleasant touch can affect pain perception. Di Lernia et al. [47] demonstrated that pleasant touch significantly reduced pain in chronic patients after only 11 minutes of stimulation. Their treatment involved controlled stimulation of CT receptors at a speed of 3 cm/s and a force of 2.5 mN. Patients with various types of chronic pain, including secondary musculoskeletal pain, neuropathic pain, and central pain, reported less severe pain following the treatment. Salgado et al. [25] investigated the effects of CT-optimal touch therapy in patients affected by fibromyalgia. They found that the patients after the treatment presented lower levels of pain, suggesting CT-optimal touch has a potential role in modulating pain. In addition, these authors also found lower levels of neurotrophins (e.g., brain derived neurotrophic factor—BDNF) in people treated with CT-optimal touch, hypothesizing that biomarkers related to neuronal plasticity such as BDNF are increased in central sensitivity syndromes, such as fibromyalgia. Indeed, the term “central sensitivity syndromes” was introduced to describe these conditions, which are characterized by an “amplified response to various nociceptive, non-nociceptive, and environmental stimuli [48]”. Therefore, it would be valuable to investigate whether CT-optimal touch can alleviate chronic pain in other clinical patient populations that often manifest chronic pain as a symptom. In neurodegenerative disease, chronic pain is a prevalent symptom. In Parkinson’s Disease, 30–95% of individuals suffer from chronic pain due to overactivation of regions involved in pain processing, particularly the ACC and insula [49, 50, 51]. Meijer et al. [52] investigated whether CT-optimal touch can reduce the chronic pain experience in Parkinson’s disease patients. The authors concluded that both CT-optimal and CT-non-optimal touch were effective in relieving chronic pain as compared to no touch. In addition, the results indicated that how CT-optimal touch is perceived, whether pleasant or not, does not influence its pain-ameliorating properties. This could be explained by the fact that the top-down process (i.e., downregulation through the insula and ACC) might rely on the activation of the CT-fibers instead of activation by the perceived pleasantness of touch. This suggests that the top-down influence is not merely a system regulating pleasantness but depends on input from CT-fibers. This concept is significant because chronic pain, such as neuropathic pain, can alter touch perception. Consequently, it has been proposed that CT-optimal touch might be ineffective for patients with neuropathic pain [40]. According to Gossrau et al. [53], patients with postherpetic neuralgia and complex regional pain syndrome reported less pleasantness than healthy controls from CT-optimal touch. The authors hypothesized that CT-fibers appear to lose their capacity to transmit pleasant tactile sensations in such allodynic conditions. The hypothesis is likely due to the central and peripheral mechanisms involved in central maladaptation processes and peripheral hyperexcitability that sustain mechanical allodynia.

Thus, while CT-optimal touch shows promise in pain management, further research is needed to explore its limitations, particularly in conditions that alter normal touch perception.

3. Discussion

Although it is known that touch-based interventions provide important effects on pain-relief perception, this field of research deserves greater attention in the future. As the number of individuals suffering from chronic pain continues to rise, there is a lack of well-documented non-invasive and non-pharmacological interventions [54]. A systematic review [34] indicates that pain during physical activity frequently hinders adherence, emphasizing the need for pain relief strategies. Therefore, clinicians must thoroughly understand patients’ pain experiences and beliefs to motivate them to follow care programs. It is noteworthy that the underlying mechanisms of chronic pain remain incompletely understood, but studies indicate that musculoskeletal pain and neuropathic pain are associated with changes in the structural and functional connectivity of brain regions involved in pain processing. Notably, the insula, ACC, and prefrontal cortex show connectivity changes linked to increased pain intensity and duration [31, 55]. Due to these largely unknown mechanisms, to discover effective treatments for chronic pain is challenging. Currently, treatment involves a multimodal approach combining pharmacological, non-pharmacological, and physical rehabilitation methods. Nevertheless, many individuals continue to suffer from chronic pain [56]. Based on the presented evidence, CT-optimal touch may be a promising intervention in reducing chronic pain, and it also appears to have a positive effect on other psychological symptoms and distress. For instance, Weze et al. [57] found that the use of CT-optimal touch, alone or in addition to other conventional medical treatments, was found to be a safe intervention for people with psychological conditions (e.g., depression and anxiety). Moreover, Schaub et al. [58] have demonstrated that the use of CT-optimal touch applied during gentle hand massage, in people affected by dementia, can reduce salivary cortisol and amylase levels. These authors suggested that hand massage provided a positive effect on agitation three hours after the intervention, but a greater effect was found in the two weeks after.

However, little is known about the neurophysiological and neurobiological mechanisms of touch-based therapies that stimulate CT-fibers.

3.1 Neurobiological Mechanisms of Touch-based Therapy

The neurophysiological process of touch begins with the activation of mechanoreceptive afferents in the skin, comprising fast-conducting, myelinated Aβ fibers and slow-conducting, unmyelinated CT afferents [59]. Aβ fibers are known to respond to a broad spectrum of touch stimuli, whereas CT afferents specifically respond to a particular type of touch, such as slow, gentle movements over the skin, even if these are not the only stimuli they respond to. Indeed, they are C-fiber low-threshold mechanoreceptors, which means they are slowly conducting afferents due to their C-fiber nature. These mechanoreceptors can respond to tactile stimuli applied with lower forces compared to those needed to activate C-nociceptors. CT afferents cannot provide helpful discriminative information due to the slow conduction velocity [1, 59]. This type of fiber can be activated by touch stimuli applied at skin temperature or with a brush, which is typically perceived as pleasant [5, 60]. Like all low-threshold mechanoreceptors, CTs have low mechanical activation thresholds. For example, they respond to the application of monofilaments (thin, calibrated threads used to measure pressure) that exert a force as low as 0.04 mN (approximately 4 mg). This is much lighter than the force required to activate other types of receptors, like C-nociceptors [8, 61]. Anatomically, it is hypothesized that the CT fibers may travel through the spinothalamic tract, or they may follow a different ascending pathway, possibly through the dorsal columns, rather than the spinothalamic tract [62]. Touch signals are transmitted from the thalamus to cortical sensory processing regions, including the insula, primary and secondary somatosensory areas, prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex, and the superior temporal sulcus [63]. Specifically, the insular cortex (IC) is pivotal in integrating sensory and affective signals about the body, forming what is known as interoception [64]. This process allows us to perceive internal bodily states and sensations like touch or pain [59]. CT-fibers project to insular brain regions, characterizing these inputs as an interoceptive modality, thereby increasing body awareness. Activation of the IC through touch enhances our perception of internal sensations, particularly their pleasant aspects, and may influence our body awareness, autonomy, and self-identity [38]. This is maybe why the activation of CT-fibers is associated with a subtle feeling of well-being, which cannot be attributed to an exteroceptive sensory source but rather to an interoceptive one (e.g., an inner, pleasant body feeling) [5, 65]. In this sense, interoceptive awareness is the ability to perceive the internal physiological state of the body, (for a review see Ceunen et al. [66]) and it is processed mainly by the insula, which is connected to several other brain structures involved in the processing of tactile information. According to Gordon et al. [67], fMRI findings showed that CT-optimal touch activated dorsal posterior insula, posterior sulcus temporalis superior, medial prefrontal cortex, dorsal ACC. In this context, Cerritelli et al. [68] studied the effects of a continuous CT-optimal touch in healthy adults, delivered while the operator, who was the person delivering the touch, focused his/her attention on two distinct aspects. In one group, the attention of the operator was focused on his/her tactile perception, feeling specific features of the tissue (e.g., temperature, density, consistency, etc…). In the other group, the attention of the operator was directed towards an auditory stimulus through headphones. The authors discovered that prolonged and sustained CT-optimal touch administered by an operator with focused tactile attention led to a significant increase in the anticorrelation between the posterior cingulate cortex and the right insula, as well as the right inferior frontal gyrus. This aspect suggests that if a particular cognitive state of the operator is sustained over time, it can elicit significant effects on the participant’s (the person receiving the touch) functional connectivity between areas processing the interoceptive and attentional value of touch. Indeed, the authors [68] proposed a plausible mechanism of action related to their findings: a touch specifically targeting tissue properties would more effectively activate CT-fibers. This action would initiate a cascade of bottom-up neurobiological events, engaging specific brain areas and networks. Additionally, this type of touch, through afferent inputs, could influence the tissue’s metabolic state and, consequently, its interoceptive signaling, potentially leading to central effects on functional connectivity.

The analgesic effect of touch could be also attributed to a reduction in the activation of pain-related neural substrates, notably the dorsal ACC and the anterior IC [69, 70]. Researchers have confirmed the power of touch in modulating pain [41, 47], which is influenced by two major nociceptive fibers: Aδ fibers and C-fibers. Specifically, Aδ fibers are slightly myelinated with small receptive fields, enabling them to quickly signal the presence of pain to the body. Their higher degree of myelination compared to C-fibers makes them responsible for the initial perception of pain. In contrast, C-fibers are unmyelinated with larger receptive fields, which allows them to transmit the intensity and persistence of pain [71]. In terms of nociception, C-fibers are considered polymodal because they respond to a variety of stimuli, including thermal, mechanical, and chemical triggers. For this reason, nociceptive pain related to the activation of C-fibers can often result in poor localization and dull pain sensation [72]. The use of touch can affect how this pain is experienced and perceived. Tactile interaction appears to exert its influence primarily through sensory mechanisms, rather than solely via distraction or other cognitive processes (such as reducing levels of anxiety, hypervigilance, and fear of pain) [73]. Tactile analgesia refers to the reduction of pain through touch, which is thought to occur because Aβ fibers can modulate or inhibit pain signals carried by Aδ and C fibers, the pathways responsible for transmitting sharp and dull pain, respectively [74]. However, although the pain-relieving effects of Aβ-mediated touch are well-studied, the analgesic potential of CT-fibers remains largely unexplored, even more in chronic pain conditions. Chronic pain is associated with maladaptive neuroplastic changes in the brain’s structure and function. In this sense, touch-based therapies might influence these changes, potentially leading to positive neurophysiological effects, also at the brain level. In addition, some touch-based interventions, like manual therapy, can influence the interaction between inflammatory mediators and peripheral nociceptors by modulating the concentration of inflammatory and pain-related mediator substances [23]. For instance, Teodorczyk-Injeyan et al. [75] found a 20% reduction in cytokine concentration (e.g., tumor necrosis factor—TNF-α and interleukine 1 beta—IL-1β), which lasted for about 2 hours after a specific manual technique. However, the exact mechanisms and effectiveness of these therapies are still under investigation and remain a topic of ongoing research and debate [25, 41, 47]. In this context, McGlone et al. [5, 65] suggested that a gentle touch on the skin, which includes somatosensory organs (i.e., sensory nervous system and cutaneous receptors) [76], during massage, stimulates components of the intracerebral oxytocinergic system that are responsible for producing effects such as reducing anxiety, depression, relieving pain, and inducing relaxation. In fact, touch-based therapies induce an increase in oxytocin levels, which has a crucial role in physical analgesia. To produce these effects in the body, oxytocin may act on the corresponding neural circuits in the central nervous system (CNS) as well as in the dorsal horn, and probably also the dorsal root ganglion [76, 77]. Oxytocin also regulates the autonomic nervous system and the vagal pathway, exhibits anti-inflammatory properties, and is well-known for its anti-stress effects, including the reduction of blood pressure and cortisol levels. This could explain why some authors found reduced levels of psychological distress after touch-based interventions [57, 58, 78]. Moreover, the IC, which is activated during CT-optimal touch, is involved in oxytocinergic modulation, facilitating bonding, trust, and processing touch with a therapeutic value, fostering robust therapeutic alliances [79]. To this aim, Kerr and colleagues [19] reported that several studies use cortisol (in plasma, saliva, and urine) as a marker of stress and oxytocin for bonding and synchrony. This latter could be used in the future studies to assess the development of therapeutic alliance, which is fundamental to achieve better outcomes. In addition, Portnova et al. [78], collected salivary samples before and after CT-optimal touch on the forearm in healthy adults. The authors found that CT-targeted stimulation induces oxytocin release, but only when the touch is individually perceived as distinctly positive and emotionally significant. Furthermore, these authors recorded EEG during resting state and at the end of CT-optimal touch stimulation, finding lower peak alpha frequency values, indicating decreased cortical arousal.

3.2 Why CT-optimal Touch for Chronic Pain Conditions?

In recent years, numerous non-pharmacological, rehabilitative, complementary and alternative medicine approaches have been developed for the treatment of chronic pain [54]. Among these, virtual reality, for example, has shown promise for managing chronic pain and improving patient outcomes [80]. Similarly, therapeutic exercise has long had a positive impact on chronic pain [81]. But why, then, introduce manual therapy and gentle touch stimulating CT fibers for the treatment of chronic pain conditions?

This question may find a potential answer in the fact that tactile stimulation of CT fibers not only appears to play a role in alleviating pain [25, 46, 47, 52], but also in enhancing psychological well-being [57, 58]. This is especially relevant since chronic pain conditions are often associated with depression and anxiety, which can exacerbate the persistence of pain [82]. Furthermore, it is a technique that does not require significant costs. Introducing gentle touch as part of the treatment for chronic pain is important for several reasons. First, gentle touch therapy, which targets CT-fibers, has been shown to activate pathways in the brain associated with emotional processing and social bonding [18, 36, 52, 67, 78]. This activation can help modulate the perception of pain by fostering a sense of comfort and safety, which is crucial for patients who often feel isolated and distressed by their chronic condition. Moreover, chronic pain is not just a physical experience but a complex interplay of physical, emotional, and psychological factors [83]. The gentle touch, by engaging CT fibers, directly influences the parasympathetic nervous system, promoting relaxation and reducing stress [39, 57, 74, 78]. This reduction in stress can help break the cycle of pain amplification, where anxiety and mood alteration exacerbate pain perception. Additionally, gentle touch therapy is non-invasive, easy to implement, and carries minimal risk, making it an accessible option for a wide range of patients. It can be used in conjunction with other treatments, enhancing their effectiveness by addressing the emotional and psychological components of chronic pain. This holistic approach not only targets the pain itself but also improves overall quality of life, providing patients with a greater sense of well-being and control over their condition.

4. Conclusion

In conclusion, touch-based interventions represent a promising avenue for therapeutic intervention, particularly in the context of chronic pain and psychological well-being. The activation of CT afferents through gentle, targeted touch has been shown to modulate neural pathways associated with pain processing and emotional regulation. However, the effectiveness of these therapies in chronic pain patients remains underexplored, given that current research primarily focuses on healthy individuals. The rising prevalence of chronic musculoskeletal pain, coupled with the scarcity of non-invasive treatment options, underscores the need for further investigation into the therapeutic benefits of touch-based interventions. Future studies should prioritize understanding the neurophysiological mechanisms underlying these therapies, ensuring their applicability across various patient populations.

Author Contributions

MB, RSC, and GAP designed the research study. GAP provided help and advice on the selection of relevant papers on the topic. MB, GAP, and RSC wrote the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest. Rocco Salvatore Calabrò are serving as one of the Guest editors and Editorial Board Members of this journal. We declare that Rocco Salvatore Calabrò had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Gernot Riedel. Giuseppe Alfredo Papa is from a private practice. We declare that there is not any form of conflict of interests.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.